Evidence map›Paper›PMID 38132101›Full record

ArticleCells2023

Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion.

Tian Liu, Liam Wetzel, Zexi Zhu, Pavan Kumaraguru, Viraj Gorthi, Yan Yan, Mohammed Zaheen Bukhari, Aizara Ermekbaeva, Hanna Jeon, Teresa R Kee and 2 more

Abstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Mitochondrial dysfunction, cause or consequence in neurodegenerative diseases?BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tian LiuDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Liam WetzelDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Zexi ZhuDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Pavan KumaraguruDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Viraj GorthiDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Yan YanDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Mohammed Zaheen BukhariByrd Alzheimer's Center & Research Institute, Department of Molecular Medicine, USF Health Morsani College of Medicine, Tampa, FL 33613, USA.
Aizara ErmekbaevaByrd Alzheimer's Center & Research Institute, Department of Molecular Medicine, USF Health Morsani College of Medicine, Tampa, FL 33613, USA.
Hanna JeonDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Teresa R KeeDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0003-4140-6341
Jung-A Alexa WooDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
David E KangDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.

Funding

Translational and Therapeutics CoreP30AG072959 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI JAGAN AYYAPPAN PILLAI · 2021 to 2026
$23.9M
SSH1-Nrf2 nexus in tipping the balance between degeneration and protection in tauopathies.R01AG080924 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI David E Kang · 2023 to 2026
$2.0M
Pathological Signatures of CHCHD10 Dysfunction in ADRDsR01NS122350 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI KANG, DAVID E · 2021 to 2025
$2.0M
Deubiquitinase USP11 in tau regulation and age-related tauopathyR01AG067741 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI KANG, DAVID E, WOO, JUNGA "ALEXA" · 2020 to 2024
$2.0M
Novel role of β-arrestins in TauopathyR01AG059721 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI WOO, JUNGA "ALEXA" · 2019 to 2023
$1.9M
Role of the Slingshot-1 pathway in APP and Tau pathogenesisRF1AG053060 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI KANG, DAVID E · 2017 to 2017
$1.9M
Deubiquitinase USP19 in TDP-43 pathogenesis.RF1NS122218 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI KANG, DAVID E, WOO, JUNGA "ALEXA" · 2022 to 2022
$1.8M
Targeting CHCHD10 to mitigate Alzheimer's disease pathogenesisR21AG070299 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI LIU, TIAN · 2021 to 2021
$411k
BLRD VA I01 BX004680NIA NIH HHS P30 AG072959NIA NIH HHS R01 AG059721NIA NIH HHS R01 AG067741NIA NIH HHS R01 AG080924NIA NIH HHS R21 AG070299NIA NIH HHS RF1 AG053060NIH HHS R01AG059721NIH HHS R01AG067741NIH HHS R01AG080924NIH HHS R01NS122350NIH HHS R21AG070299NIH HHS RF1AG053060NINDS NIH HHS R01 NS122350NINDS NIH HHS RF1 NS122218
6 · The paper itself

Abstract

Coiled-coil-helix-coiled-coil-helix domain-containing 10 (CHCHD10) is a nuclear-encoded mitochondrial protein which is primarily mutated in the spectrum of familial and sporadic amyotrophic lateral sclerosis (ALS)-frontotemporal dementia (FTD). Endogenous CHCHD10 levels decline in the brains of ALS-FTD patients, and the CHCHD10

Indexed as

Amyotrophic Lateral SclerosisFrontotemporal DementiaAnimalsDNA-Binding ProteinsHumansMammalsMetalloproteasesMitochondrial ProteinsMitophagyMutationProtein KinasesCHCHD10 protein, humanDNA-Binding ProteinsMetalloproteasesMitochondrial ProteinsPARL protein, humanProtein KinasesCHCHD10mitophagyPARLPINK1TDP-43

Identifiers

PMID38132101
PMCPMC10741529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.